NRG
NVS icon

Nemes Rush Group’s Novartis NVS Stock Holding History

Nemes Rush Group’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.5K Hold
80
– – ﹤0.01% 539
2026
Q1 		$12.2K Hold
80
– – ﹤0.01% 527
2025
Q4 		$11K Buy
+80
New +$10.5K ﹤0.01% 537
2024
Q2 		– Sell
-466
Closed -$45.1K – 655
2024
Q1 		$45.1K Hold
466
– – 0.01% 285
2023
Q4 		$47.1K Hold
466
– – 0.01% 261
2023
Q3 		$47.5K Hold
466
– – 0.01% 257
2023
Q2 		$47K Buy
+466
New +$46.6K 0.01% 271

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Nemes Rush Group's NVS Position: Q2 2026 in Review

Nemes Rush Group held its Novartis (NVS) position steady in Q2 2026 at 80 shares worth $12.5K. The position accounts for ﹤0.01% of the portfolio, ranked #539.

Nemes Rush Group first reported a position in NVS in Q2 2023 and has held it in 7 quarters since. The position peaked at $47.5K in Q3 2023. 1,623 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Nemes Rush Group held 80 shares of Novartis worth $12.5K as of Q2 2026.
  • Nemes Rush Group left its Novartis share count unchanged in Q2 2026.
  • Novartis made up ﹤0.01% of Nemes Rush Group's portfolio in Q2 2026, its #539 holding.
  • Nemes Rush Group first reported a position in Novartis in Q2 2023 and has held it in 7 quarters since.
  • Nemes Rush Group's Novartis position peaked at $47.5K in Q3 2023.
  • 1,623 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Nemes Rush Group's 13F filing for Q2 2026, filed 14 Aug 2026.